GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.
The Department for Work and Pensions (DWP) has come under fire in a scathing report by the Public Accounts Committee released on Friday, which criticised the handling of claimants with complex ...
The detection of adverse drug reactions (ADRs) by a traditional passive reporting system and by a method involving patient and provider interviews was studied. The study sample consisted of ...
By Erica L. Green and Hamed Aleaziz Reporting from Washington The Trump administration on Wednesday threatened federal employees with “adverse consequences” if they fail to report on ...
The study in Nature Medicine explores the potential wider benefits and risks of diabetes drugs GLP-1 receptor agonists. Besides weight loss, these drugs might reduce risks for neurocognitive disorders ...
In report published in Nature Medicine ... Many of the health benefits listed in the new paper are known. The U.S. Food and Drug Administration (FDA) recently approved adding to Wegovy's label ...
Most also said such benefits would be critical for return-to-office plans. But they reported difficulting obtaining C-suite buy-in, despite more than 80% of respondents reporting a belief that ...
A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...
Weight loss drugs like Ozempic and wegovy have become ... inflamed pancreas (acute pancreatitis), serious allergic reactions, low blood sugar levels (hypoglycemia), diabetic retinopathy issues ...
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study reporting ... benefits are well established, information is sparse on the ...
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting ... drugs. They found widespread associations with benefits ...